Publication | Open Access

A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings

VaccinationCancer ImmunosurveillanceGenitourinary CancerImmunologyTumor ImmunityCancer Vaccine Tg4010Phase Ii StudyTherapeutic VaccineT Cell ImmunityImmunotherapyMedicineRadiation OncologyImmunological Findings